⌕
Tenet Healthcare · THC · NYSE
Tenet 60 · Solid
Compare
$291.54+1.93%At closeTenet 60 · Solid
$291.54+5.51 (+1.93%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
$291.540.00 (0.00%)
After hours: Nov 16, 2026, 4:21 PM ET· last 1-minute bar

Tenet Healthcare (THC) Earnings Forecast

Analysts expect Tenet Healthcare (THC) to earn $22.57 a share in FY26, the average of 12 estimates as of Nov 13, 2026.

Sources Analyst estimates EstimatesConsensus as of How we compute thisNot investment advice
FY26 consensus EPS
$22.57
12 analysts
FY27 consensus EPS
$20.35
12 analysts · low $18.05, high $23.38
EPS revisions, 7 days
0.0%
$22.57 to $22.57
Disagreement, FY26
11.6%
high to low, $20.97 to $23.59

Consensus estimates only. Analysts' price forecasts and ratings are not licensed here.

Consensus as of Nov 13, 2026 · we check it nightly

Analysts expect Tenet Healthcare to earn $27.10 a share in FY29, growing about 6% a year; 3 analysts publish an estimate for FY29.

Forward P/E · FY26E
12.7×
$286.03 (as of close, Nov 13, 2026) ÷ $22.57 consensus EPS
Coverage · FY26
12 · 15
EPS estimates · revenue estimates

Are estimates going up or down lately?

The FY26 EPS consensus is $22.57, up 0.0% in 90 days, on the 7 days of it our record holds. Every figure compares one fiscal period at both ends.

EPS consensus, change over the last 90 days. One step per nightly change.

−0.0%+0.0%+0.0%FY27 +0.0%FY26 +0.0%Nov 6Nov 13
EPS30 days90 daysshown above
FY2612 analysts7 of 30 days0.0% so far7 of 90 days0.0% so far
FY2712 analysts7 of 30 days0.0% so far7 of 90 days0.0% so far
Sep '2613 analysts7 of 30 days0.0% so far7 of 90 days0.0% so far
Dec '2612 analysts7 of 30 days0.0% so far7 of 90 days0.0% so far

Contributors at both ends of the window: FY26 11 and 12. A change in the average can come from a new contributor as much as from a changed mind, so both counts stay in view.

Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.

If the Street is right, what does that imply for the share price?

Price as of close, Nov 13, 2026 · consensus as of Nov 13, 2026

At 8.0 times earnings, which is what Tenet Healthcare trades at today, the FY27 consensus of $20.35 works out to $162 a share.

Consensus EPS · FY27
$20.35
12 analysts · low $18.05, high $23.38 · thin coverage
Multiple · today's trailing P/E
8.0×
$286.03 (as of close, Nov 13, 2026) ÷ $35.97, the last four reported quarters, including EPS computed by Tenet
×
Receipt · THC · FY27Nov 13, 2026
Implied, a share
$162

Range on the low and high estimate: $144 to $186.

$144 low$186 high
20.35 × 8.0, to the dollar
Drag the multipleShaded: where Tenet Healthcare's P/E sat at each fiscal year end, FY08 to FY25. Each dot is one year.
5×10×20×30×40×48×
today 8.0×5-yr avg 10.5×10-yr median 12.9×$162 a share

Each point on the line is a multiple, and the flag is the price it implies for FY27. Past multiples are context, not a guide to future ones.

This is multiplication, not a forecast. It assumes the market pays the multiple you chose and that the consensus is right. Both are often wrong.

You are paying 12.7 times the FY26 consensus for earnings the Street expects to shrink about 1% a year to FY28. A falling number is not a growth rate, so the multiple is not divided by it here.Show today's multiple against its own recordHide the multiple record
Trailing P/E at each fiscal year end, FY08 to FY25 · over 12 fiscal years, with 1 year of near-zero earnings left out. The mark is the median of the last 10.
8.0× today
3.4× low42.9× high
12.9× median
Forward 12.7× is a different measure, so it is not placed on a trailing record. Today's mark is the trailing 8.0×, on the same basis as every year behind it.

How much do analysts disagree?

For FY29, estimates run from $26.68 to $27.98 around an average of $27.10, drawn by 3 analysts.

FY26E12 analysts
$20.97 to $23.59 · 11.6%
FY27E12 analysts
$18.05 to $23.38 · 26.2%
FY28E6 analysts
$19.10 to $25.53 · 29.1%
FY29E3 analysts
$26.68 to $27.98 · 4.8%

The dashed line is FY25 filed $15.49, on the GAAP basis.

A wide spread is disagreement, not risk; a narrow one is agreement, not accuracy. Later years are always wider because fewer people forecast them. Bars in amber rest on fewer than 15 analysts. The tick on each bar is the average.

Is next quarter a high bar or an easy one?

Analysts expect Tenet Healthcare to earn $5.32 a share in the December quarter, the average of 12 estimates. Results are expected by Feb 12, 2027. Last quarter, which ended in September, Tenet Healthcare earned $12.41 a share. Analysts had expected $4.68, so it came in 165.4% higher.

$4.22
$5.32high $6.04
low $4.44
+26.0%crosses bases
Dec 2025 quarterfiled · GAAPDec 2026 quarterconsensus · Street basis · 12 analysts
Expected report
Feb 12, 2027
Expected by Feb 12. An estimate, not a date the company has set. Companies move it.
Revenue expected · December quarter
$5,682.8M
11 analysts, 5,602.8 to 5,752.9 in $M · 5,527.0 in the same quarter a year ago

The step from a filed quarter to a consensus crosses bases: the filed figure is the company's own GAAP number and the consensus is on the Street's basis. It is printed with both bases named, not as growth. Last quarter's comparison is measured against the last estimate we hold for that quarter rather than the one from the night before the report, because the nearest estimate we hold for it was recorded after the company had already reported. For the March quarter, analysts expect $4.46 a share.

Does Tenet Healthcare usually beat or miss?

So far we have checked 10 quarters, of which 10 came in above the estimate we held. We add a quarter to this record each time Tenet Healthcare reports. The next report is expected by Feb 12, 2027.

We started recording estimates on Nov 6, 2026, so quarters that reported before that date cannot be checked.

Before our record
Dec '23
Our record, one quarter per report
Mar '24left out · basis
+38.4%
Jun '24reaction
+4.8%
+106.8%
Sep '24reaction
+16.7%
+28.4%
Dec '24reaction
−9.1%
+36.7%
Mar '25reaction
+11.7%
+9.2%
Jun '25reaction
−10.7%
+15.7%
Sep '25reaction
−5.3%
+3.8%
Dec '25reaction
−0.7%
+92.3%
Mar '26reaction
−1.7%
+130.9%
Jun '26reaction
+17.2%
+165.4%
Sep '26reaction
+0.8%
reportsFeb 12
Dec '26
Checked so far
10 quarters
one more every report
Beat expectations
10 of 10
full details on the Earnings tab
Share price reaction
+2.4%
the average over all 10 checked quarters, one session each, timed to each release
Typical gap vs estimate
+37.5%
shown once 4 quarters are checked

Checked against the company's reported figure (GAAP) and the average estimate we recorded the night before its results release. Where analysts' number is on an adjusted basis, we leave the comparison out rather than force it. We started recording estimates for Tenet Healthcare on Nov 6, 2026, so earlier quarters cannot be checked, and we never fill them in after the fact. Jun '24, Sep '24, Dec '24, Mar '25, Jun '25, Sep '25, Dec '25, Mar '26, Jun '26, Sep '26 are drawn hollow: we hold no estimate for those quarters recorded strictly before the report, so it is scored against the last estimate we hold rather than the night-before one.

The Street expects sales to grow 1.0% in FY27 and EPS −9.8%. The net margin moves from 9.1% to 8.4%, and the implied share count from about 89.7M to 92.5M, so these numbers assume no buyback.Show the decomposition and the margin ladderHide the decomposition
FY27 EPS growth, in points
Revenue growth+1.0
Net margin change−8.0
Share count change−2.8
EPS growth−9.8
Legs are rounded to a tenth of a point and the largest remainder carries the difference, so they add to the total. Implied shares = consensus net income ÷ consensus EPS, a direction rather than a decimal.
12 analysts publish an EPS estimate for FY26 and 15 publish revenue. Coverage thins with distance: 3 EPS estimates for FY29. Consensus figures are on the Street's basis and filed figures are GAAP; we label the gap, we do not explain it away.Show coverage by year and over timeHide the coverage chart
Analysts by fiscal year · outlined revenue, filled EPS. Amber marks a panel of fewer than 15.
1512
FY26E
1412
FY27E
146
FY28E
83
FY29E
The FY26 panel held 11 analysts when our record of it began on Nov 6, 2026 and holds 12 tonight.

The full consensus, year by year

Consensus as of Nov 13, 2026 · filed figures as reported
Revenue · $Bfiled · consensus average · band = low to high
192225historyStreet forecastFY22FY25FY29E

Coverage thins with distance: 15 revenue estimates for FY26, 8 for FY29.

Diluted EPS · $filed · consensus average · band = low to high
2.0617.9633.86historyStreet forecastFY22FY25FY29E

Out-year bands widen as fewer analysts publish: 12 EPS estimates for FY26, 3 for FY29.

Fiscal yearRevenue $BYoYEPS $YoYEBITDA $BNet inc. $BShares BAnalysts rev · EPSFwd P/E
FY25Filed21.3—15.49————as filed8.0×
FY26E22.322.2 to 22.6▲4.7%a22.5720.97 to 23.59▲45.7%a4.32.00.0915 · 1212.7×
FY27E22.522.3 to 23.1▲1.0%20.3518.05 to 23.38▼9.8%4.11.90.0914 · 1214.1×
FY28E23.523.0 to 24.4▲4.4%22.1319.10 to 25.53n/cb4.32.00.0914 · 612.9×
FY29E24.524.2 to 25.1n/cb27.1026.68 to 27.98n/cb4.92.50.098 · 310.6×

Average estimate with low to high beneath. Amber counts mark thin coverage and thin rows carry an amber rule. Shares = consensus net income ÷ consensus EPS, a direction rather than a decimal. The filed row's last column is today's price over the last four reported quarters, the one trailing multiple in that column. a This step crosses the seam: last year is a filed GAAP actual and this year is a consensus estimate, so the two are not prepared on one basis. b More than a third of the analyst panel changed between these two years, so the difference of the two averages measures the panel rather than the forecast.

These are consensus estimates: what analysts expect the business to earn, not where they think the stock trades. Coverage thins and the low to high band widens in the out-years. Context, not advice.

Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: 12 EPS estimates for FY26, 15 for revenue. Not investment advice.

What do analysts expect Tenet Healthcare to earn in FY26?

Analysts expect Tenet Healthcare to earn $22.57 a share in FY26, the average of 12 estimates as of Nov 13, 2026.

What is Tenet Healthcare's earnings forecast for FY27?

The FY27 consensus for Tenet Healthcare is $20.35 a share from 12 analysts, with a low of $18.05 and a high of $23.38, as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.